-->

Welcome To Allmpus

We are young & growing Pharma company In India

Manufacturers of life-saving drugs and pharmaceutical intermediates (PIs) need the staunchest supply chains, quality assurance, and regulatory expertise.


PHARMA INTERMIDIATE

Voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi

Read More

ACTIVE PHARMACUTICAL INGEDIENTS (API)

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore

Read More

API IMPURITY STANDARD

Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia

Read More

Manufacturers of life-saving drugs and pharmaceutical intermediates (PIs) need the staunchest supply chains, quality assurance, and regulatory expertise. For this reason, many pharmaceutical companies and CMOs look to ALLMPUS for global sourcing of pharmaceutical intermediates. Our Specialty Areas

about
  • Strict Quality Practices

  • New Advanced Instruments

  • Customized Lab Solutions

About Us

At Allmpus we are doing contract research and providing R&D products to various pharmaceutical companies. We are guided at all times by the promise of caring for our customers’ research and development. To achieve this objective we have invested in a research laboratory, continuous learning and technology to develop high quality research and affordable pharmaceuticals products for business & healthcare needs.

about
  • professional Customer Relationship

  • 97% customer satisfaction rate

  • Professional staff

While we believe we are more than just numbers, the depth of our laboratories is pretty impressive.

Accreditation

backgrounds

ANDD

Allmpus New Drug Discovery

Allmpus pursuit of innovative drug discovery started over in 2022 with a vision to find cures for the unmet medical needs of patients across the globe by providing novel therapeutic options.

Allmpus set up its first Innovation centre focusing on small molecule research at Amravati, Maharashtra, India in 2022.

As a part of drug discover we are focusing on design & Synthesis of new chemical entities (NCE’S), One of the pivotal moments in Allmpus innovation journey came in 2024 when we got potent preclinical candidate an Anti-Cancer agents.

Subsequently, over the years, Allmpus has struck multiple potent molecules on different Therapeutic target like CDK1 & CDk2, EGFR, JACK etc and there studies at preclinical stage is going at stages of clinical development.

Our Pipeline is comprised of platform, and Small Molecules targeting the spectrum of Cancer.

Did not find product of your interest ?

Help us to understand your requirements, Contact us here and We shall come back in 48hr with our proposal.

Research Article & Review

post image

Partnership to Increase COVID19 Testing Capacity and Track All COVID-19

With 200 access points across the country a comprehensive logistics network, we have proven to be an important partner in the response to COVID-19, having governmen

+ Read More
Sign Up For Alerts, News, Thoughts, And Insights
Have A Question! Contact Us